covid 19 News and Research

RSS

Big leagues balk at endorsing vaccination

Santa Clara County, where the San Francisco 49ers train and play their NFL home games, has one of the highest covid vaccination rates in California.

22 Jul 2021

Epstein-Barr virus reactivation may play a role in long COVID and severe COVID-19 cases

Two recently published studies available on the National Institutes of Health website indicate Epstein-Barr virus (EBV) reactivation may play a role both in the development of long COVID symptoms, as well as severe COVID-19 cases.

22 Jul 2021

Emerging SARS-CoV-2 mutations L452R & Y453F evade cellular immunity

The study, published in the journal Cell Host & Microbe, also showed emerging mutations L452R and Y453F in the SARS-CoV-2 spike receptor-binding motif evade (HLA) A24-restricted cellular immunity. Meanwhile, the L452R enhances spike stability, viral fusogenicity, and viral infectivity. Hence, the findings suggest that HLA-restricted cellular immunity potentially affects the evolution of viral phenotypes.

22 Jul 2021

Scientist explore conserved RNA elements as potential targets for anti-SARS-CoV-2 drugs

The study, published in the journal Angewandte Chemie International Edition, identified many small molecules that bind to certain parts of the SARS-CoV-2 genome that are less likely altered by mutations using dedicated substance libraries. The scientists derived key functional units and groups in ligands for effective and safe targeting of SARS-CoV-2 RNA.

22 Jul 2021

Two-dose regimen of mRNA vaccines provides protection against Alpha and Beta variants in France

Over the past six months, the World Health Organization has categorized four SARS-CoV-2 variants as being "of concern" because they are more transmissible or may escape the immune response.

22 Jul 2021

SARS-CoV-2 proteins manipulate autophagy

The ongoing coronavirus pandemic (COVID-19) has claimed more than 4.1 million lives worldwide. This pandemic is caused by a novel single-stranded RNA virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that was first reported in 2019 in Wuhan, China. The rapid spread of this virus is attributed to its high infectiousness and its ability to escape and counteract host immune responses, e.g., autophagy.

22 Jul 2021

Experts call for immediate action to ensure physical activity is built into everyday lives

Not enough progress has been made to address physical inactivity worldwide, with adolescents and people living with disabilities (PLWD) among the least likely populations to have the support needed to meet the World Health Organization (WHO)'s physical activity guidelines.

22 Jul 2021

Study lays out challenges of achieving equity in communication for diverse patients at hospital discharge

A new study by research, quality improvement and health equity experts at Massachusetts General Hospital in The American Journal of Managed Care lays out the challenges of achieving equity for diverse patients in communication at hospital discharge.

21 Jul 2021

New method predicts if COVID-19 clinical trials will be completed or suspended

In order to win the battle against COVID-19, studies to develop vaccines, drugs, devices and re-purposed drugs are urgently needed.

21 Jul 2021

SARS-CoV-2 can be transmitted by cats

Researchers in The Netherlands have warned that domestic cats may play a role in the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

21 Jul 2021

Study evaluates ICU workers' mental health during the COVID-19 pandemic

A high proportion of staff working in intensive care units during the COVID-19 pandemic have experienced mental health conditions, according to a new study.

21 Jul 2021

Traditional Japanese dish may hold an answer to COVID-19

Natto, a fermented soybean dish often served for breakfast in Japan, originated at the turn of the last millennium but may hold an answer to a modern problem: COVID-19, according to a new study based on cell cultures.

21 Jul 2021

Combination antibody therapies retain potency against SARS-CoV-2 variants, FDA / HHS research

Researchers in the United States have conducted a study showing that while variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can compromise the effectiveness of single therapeutic antibodies at preventing severe coronavirus disease 2019 (COVID-19), many combination antibody products remain potent against the variants.

21 Jul 2021

Older people appear to have diminished antibody response after COVID-19 vaccination

Older people appear to have fewer antibodies against the novel coronavirus, a new laboratory study from Oregon Health & Science University suggests.

21 Jul 2021

Existing drug may be effective in treating COVID-19

A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19.

21 Jul 2021

Global consortium publishes findings on all-cause mortality during COVID-19 pandemic in 22 countries

A global consortium representing 27 institutions has published findings comparing mortality in the previous five years to deaths between January and August 2020 in the first wave of the pandemic.

21 Jul 2021

Doctors have a poor understanding of long COVID in children, report says

The clinical definition of long COVID in children is at present very limited and poorly understood by doctors, according to a new report published today [21 July].

21 Jul 2021

WFP and WHO launch joint project to improve emergency response to health crises

Following the recent G20 side event co-hosted by the Italian Government and the United Nations World Food Programme (WFP) focusing on the role of logistics in current and future health emergencies, WFP and the World Health Organization (WHO) are launching INITIATE2, a joint project to bring together emergency actors, research and academic institutions, and international and national partners to promote knowledge sharing and skills transfer for improved emergency response to health crises.

21 Jul 2021

U.S. sees sharp decrease in life expectancy largely due to COVID-19 pandemic, CDC says

New preliminary data from the United States Centers for Disease Control and Prevention (CDC) suggests that average life expectancy in the United States fell by 1.5 years over 2020.

21 Jul 2021

Scientists identify gut microbiota dysbiosis as a potential risk factor for long COVID

A study in Norway has recently highlighted a significant association between gut microbiota alteration and persistent respiratory dysfunction in coronavirus disease 2019 (COVID-19) patients.

21 Jul 2021

covid 19 News and Research

Big leagues balk at endorsing vaccination

Epstein-Barr virus reactivation may play a role in long COVID and severe COVID-19 cases

Emerging SARS-CoV-2 mutations L452R & Y453F evade cellular immunity

Scientist explore conserved RNA elements as potential targets for anti-SARS-CoV-2 drugs

Two-dose regimen of mRNA vaccines provides protection against Alpha and Beta variants in France

SARS-CoV-2 proteins manipulate autophagy

Experts call for immediate action to ensure physical activity is built into everyday lives

Study lays out challenges of achieving equity in communication for diverse patients at hospital discharge

New method predicts if COVID-19 clinical trials will be completed or suspended

SARS-CoV-2 can be transmitted by cats

Study evaluates ICU workers' mental health during the COVID-19 pandemic

Traditional Japanese dish may hold an answer to COVID-19

Combination antibody therapies retain potency against SARS-CoV-2 variants, FDA / HHS research

Older people appear to have diminished antibody response after COVID-19 vaccination

Existing drug may be effective in treating COVID-19

Global consortium publishes findings on all-cause mortality during COVID-19 pandemic in 22 countries

Doctors have a poor understanding of long COVID in children, report says

WFP and WHO launch joint project to improve emergency response to health crises

U.S. sees sharp decrease in life expectancy largely due to COVID-19 pandemic, CDC says

Scientists identify gut microbiota dysbiosis as a potential risk factor for long COVID

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News